TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
antioxydants
systematic review
meta-analysis
network meta-analysis
Beta carotene
-
Vitamin c
-
Vitamin e
Select
cardiovascular prevention
diabetes type 2
peripheral vascular diseases
post acute coronary syndromes
post myocardial infarction
All type of patient
uncoded clinical condition ***
Diabetic patients
patients undergoing dialysis
primary prevention
secondary prevention in patients with CAD
antioxydant
vitamine E
beta carotene
vitamin c
vitamin e
vs placebo or control
Filter
hide ongoing
show ongoing
hide ongoing
all ROB
Show all trials
Show only trial at low risk of bias
Hide exploratory trials
all results
Show all trials
Show only trial with conclusive result
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
MA
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
Description
Synopsis
Comparison
Treatments
Patients
Characteristics
Method
Risk of bias
References
None
Tools
Indexation
Results
Global trial result
Main results
All results
All result tag
NCT results
All cause death (50)
Cardiovascular death (44)
cardiovascular events (42)
stroke (fatal and non fatal) (33)
Coronary event (24)
Non fatal MI (23)
ischemic stroke (23)
Haemmorhagic stroke (19)
Non fatal stroke (17)
Amputation (6)
Coronary death (2)
cardiovascular death, MI, stroke (1)
new-onset diabetes (1)
new-onset atrial fibrillation (1)
Options
Numeric
bar chart
forest plot
medians
Trial
Studied trt
Control trt
patients
tags
ROB
Trial result
All cause death
Cardiovascular death
cardiovascular prevention
beta carotene
ATBC beta carotene, 1994
beta carotene
placebo
Low risk of bias
-
11%
CARET beta carotene, 1996
beta carotene
placebo
Low risk of bias
negative
17%
26%
SCP beta carotene, 1990
beta carotene
placebo
Low risk of bias
negative
7%
NSCP (Green) beta carotene, 1999
beta carotene
placebo
Low risk of bias
negative
-49%
-51%
PHS beta carotene, 1996
beta carotene
placebo
Low risk of bias
suggesting
-91%
-90%
WHS beta carotene, 1999
NCT
beta carotene
placebo
Low risk of bias
negative
7%
17%
WACS beta-caroten, 2007
NCT
beta carotene
placebo
Low risk of bias
negative
3%
15%
ATBC 2nd prev subgroup (b carotene), 1998
beta carotene
placebo
Low risk of bias
negative
vitamin c
WACS vitamin C, 2007
NCT
vitamin C
placebo
Low risk of bias
negative
3%
9%
PHS II vitamin C, 2008
NCT
vitamin C
placebo
Low risk of bias
negative
6%
1%
vitamin e
GISSI, 1999
vitamin E
control
Risk of bias
negative
-8%
-6%
PPP, 2001
vitamin E
control
Risk of bias
negative
7%
-14%
ATBC vitamin E, 1994
vitamin E
placebo
Low risk of bias
suggesting
-2%
CHAOS, 1996
vitamin E
placebo
Low risk of bias
suggesting
29%
10%
HOPE, 2000
vitamin E
placebo
Low risk of bias
negative
5%
AREDS, 2001
vitamin E
placebo
Low risk of bias
negative
5%
Linxian, 1993
vitamin E
placebo
negative
WACS vitamin E, 2007
NCT
vitamin E
placebo
Low risk of bias
negative
2%
-4%
PHS II vitamin E, 2008
NCT
vitamin E
placebo
Low risk of bias
negative
3%
3%
WHS vitamin E, 2005
NCT
vitamin E
placebo
Low risk of bias
negative
ASAP, 2000
vitamin E
placebo
Low risk of bias
negative
100%
SPACE, 2000
vitamin E
placebo
Low risk of bias
suggesting
9%
-39%
HOPE renal insufficiency subgroup, 2004
vitamin E
placebo
Low risk of bias
negative
-10%
-1%
ATBC 2nd prev subgroup (vitamin E), 1998
vitamin E
placebo
Low risk of bias
negative
peripheral vascular diseases
vitamin e
Livingstone, 1958
placebo
-
Hamilton, 1953
placebo
-
×
Modal title